Latest Happenings

Pembrolizumab With or Without Bevacizumab in Platinum-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Phase 2 Trial (The Lancet Oncology, Feb 2025)

Wan-Qin Chong, MBBS a ∙ Jia-Li Low, MBBS a ∙ Joshua K Tay, PhD b,d ∙ Thi Bich Uyen Le, BSca ∙ Grace Shi-Qing Goh, BSc g ∙ Kenneth Sooi, MBBS a ∙ Hui-Lin Teo, MBBS h ∙ Seng-Wee Cheo, MD a ∙ Regina Tong-Xin Wong, BSc g ∙ Jens Samol, MD h,j,k ∙ Ming-Yann Lim, MBBS i ∙ Hao Li, MBBS i ∙ Niranjan Shirgaonkar, MSc l ∙ Shumei Chia, PhD l ∙ Lingzhi Wang, PhD f,g ∙ Anil Gopinathan, MBBS c ∙ Donovan Kum-Chuen Eu, MBBS b ∙ Raymond King-Yin Tsang, MBChB b,d ∙ Prof Kwok-Seng Loh, MBBS b,d ∙ Prof Han-Chong Toh, MBBS m ∙ Nicholas Syn, MBBSe ∙ Li-Ren Kong, PhD f,g ∙ Ramanuj Dasgupta, PhD l ∙ Bee-Choo Tai, PhD n ∙ Yaw-Chyn Lim, PhD

Pembrolizumab With or Without Bevacizumab in Platinum-Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Randomized, Open-Label, Phase 2 Trial (The Lancet Oncology, Feb 2025) Read More »

Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia (Leukemia, Nov 2024)

Xiaoman Shao # 1, Rui Yokomori # 1, Jolynn Zu Lin Ong 1, Haoqing Shen 1, Dennis Kappei 1 2 3, Leilei Chen 1 3, Allen Eng Juh Yeoh 1 3 4, Shi Hao Tan 1, Takaomi Sanda 5 6 7 8 Affiliations Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore. Department of Biochemistry,

Transcriptional regulatory program controlled by MYB in T-cell acute lymphoblastic leukemia (Leukemia, Nov 2024) Read More »

ZBTB48 is a Priming Factor Regulating B-Cell-Specific CIITA Expression (The EMBO Journal, Dec 2024, Cover story)

Grishma Rane 1, Vivian L S Kuan 1, Suman Wang 2, Michelle Meng Huang Mok 1, Vartika Khanchandani 1, Julia Hansen 1, Ieva Norvaisaite 1, Naasyidah Zulkaflee 1, Wai Khang Yong 1, Arne Jahn 3 4 5 6, Vineeth T Mukundan 1, Yunyu Shi 2, Motomi Osato 1, Fudong Li 2, Dennis Kappei 7 8 9 Affiliations 1Cancer Science Institute of Singapore, National University

ZBTB48 is a Priming Factor Regulating B-Cell-Specific CIITA Expression (The EMBO Journal, Dec 2024, Cover story) Read More »

Fratricide-resistant CD7-CAR T cells in T-ALL (Nature Medicine, Sept 2024)

Bernice L Z Oh 1 2, Noriko Shimasaki 2, Elaine Coustan-Smith 2, Esther Chan 3, Limei Poon 3, Shawn H R Lee 1 2, Frances Yeap 1 2, Lip Kun Tan 3, Louis Y A Chai 4, Nina Le Bert 5, Nicole Tan 5, Antonio Bertoletti 5, Siew Peng Chen 2, Francesca Del Bufalo 6, Marco Becilli 6, Franco Locatelli 7 8, Allen E J Yeoh 9 10 11 12, Dario

Fratricide-resistant CD7-CAR T cells in T-ALL (Nature Medicine, Sept 2024) Read More »

Super Enhancer Acquisition Drives Expression of Oncogenic PPP1R15B that Regulates Protein Homeostasis in Multiple Myeloma (Nature Communications, Aug 2024)

Sinan Xiong 1 2, Jianbiao Zhou 3 4 5, Tze King Tan 2, Tae-Hoon Chung 2, Tuan Zea Tan 2, Sabrina Hui-Min Toh 2, Nicole Xin Ning Tang 2, Yunlu Jia 6, Yi Xiang See 2, Melissa Jane Fullwood 2 7 8 9, Takaomi Sanda 1 2, Wee-Joo Chng 10 11 12 13 Affiliations 1. Department of Medicine, Yong Loo Lin School of

Super Enhancer Acquisition Drives Expression of Oncogenic PPP1R15B that Regulates Protein Homeostasis in Multiple Myeloma (Nature Communications, Aug 2024) Read More »